Cahill represented the joint book-running managers and the co-managers in connection with the Rule 144A offering of $1,250,000,000 aggregate principal amount of 5.25% Senior Secured First Priority Notes due 2021 by HD Supply, Inc., one of the largest industrial distributors in North America. Proceeds from the offering were used to refinance existing indebtedness.
Tags: Cahill Gordon & Reindel LLP | New York
The Firm represented Merrill Lynch, Pierce, Fenner & Smith Incorporated, Goldman, Sachs & Co., J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC as joint book-running managers in connection with a public offering by UnitedHealth Group Incorporated of $750 million aggregate principal amount of 1.400% Notes due December 15, 2017, $500 million aggregate principal amount of 2.300% Notes due December 15, 2019 and $750 million aggregate principal amount of 2.875% Notes due December 15, 2021. The offering closed on December 8, 2014. More >>
Tags: Simpson Thacher & Bartlett LLP | New York
Ropes & Gray advised Chicago- and Nashville-based Cressey & Company, a leading health care-focused private investment firm, in the formation of Cressey & Company Fund V, LP. Fund V, which closed with a combined $615 million in limited partner and general partner capital commitments, will focus on investing in premier platform businesses and accelerating growth organically and through acquisitions. The fund launched in July 2014; its closing was announced Dec. 8. More >>
Tags: Ropes & Gray LLP | Boston
Debevoise & Plimpton LLP is advising Protective Life Corporation (“Protective”) in a definitive agreement under which Dai-ichi Life Insurance Company, Limited (“Dai-ichi Life”) will acquire all outstanding shares of Protective for $70.00 per share in cash, or a total transaction value of approximately $5.7 billion. More >>
Tags: Debevoise & Plimpton LLP | New York
Davis Polk advised China Cinda Asset Management Co., Ltd. (China Cinda) in connection with a private placement of US$230 million Regulation S guaranteed senior notes issued by China Cinda’s wholly owned subsidiary, China Cinda Finance (2014) II Limited. The notes are guaranteed by China Cinda (HK) Holdings Company Limited, a wholly owned subsidiary of China Cinda, and are supported by a keepwell deed and a deed of equity interest purchase, investment and liquidity support undertaking from China Cinda. More >>
Tags: Davis Polk & Wardwell LLP | Beijing | Hong Kong | LondonCahill represented Wells Fargo Securities, Citigroup, and Morgan Stanley as joint book-running managers, and the co-managers in connection with the public offering of $225,000,000 aggregate principal amount of 5.375% Senior Notes due 2024 by Tenneco Inc., one of the world’s leading manufacturers of clean air and ride performance products and systems for light vehicle, commercial truck and off-highway applications. Proceeds from the offering were used to repurchase Tenneco’s existing notes due 2018.
Tags: Cahill Gordon & Reindel LLP | New York
Morgan Lewis represented BTG plc as M&A counsel in its $475 million acquisition of PneumRx Inc., a venture-backed lung treatment specialist based in California. The deal was announced on December 4, 2014.
BTG will pay $230 million in cash initially and up to $245 million in performance-related payments under the terms of the agreement. More >>
Tags: Morgan, Lewis & Bockius LLP | London
Herbert Smith Freehills has advised the Investment Board of the Government of Nepal on its project development agreement (PDA) with Indian public sector undertaking SJVN Limited to develop the 900 megawatt, US$1.1 billion Arun-3 Hydro Electric Project (the Project). This agreement follows on from the firm advising the Government of Nepal on the US$1.4 billion Upper Karnali Hydro Power Project PDA earlier this year, which is Nepal’s biggest ever foreign investment deal. More >>
Tags: Herbert Smith Freehills Kramer LLP | Brussels | LondonDLA Piper has advised Pfizer on the US$635 million acquisition of commercial vaccines from Baxter, with the transaction closing successfully on 1 December 2014.
The deal included the meningitis prevention vaccine NeisVac-C and the well-known vaccine FSME-IMMUN/Ticovac. Furthermore, Pfizer acquired the production facility in Austria, where the two vaccines are manufactured. More >>
Tags: DLA Piper | Vienna